AJP Spring 2021: Rethinking the Use of SCLT-2 Inhibitors: Cardiovascular Risk Reduction to Heart Failure
English
Recorded Courses
hosted byArizona Pharmacy Association (AzPA)
hosted byArizona Pharmacy Association (AzPA)
attend it anywhere online
category
Pharmacy, Medicine
price
$0.00 - $20.00
AJP Spring 2021: Rethinking the Use of SCLT-2 Inhibitors: Cardiovascular Risk Reduction to Heart Failure is organized by Arizona Pharmacy Association (AzPA). This Course has been approved for a maximum of 1 Contact Hour.
Released: 2021-04-15
Expires: 2024-04-15
Target Audience: Pharmacists
Learning Objectives:
• Describe the relationship between diabetes and cardiovascular disease.
• Interpret the findings of the SGLT-2 inhibitor cardiovascular and heart failure outcomes trials.
• Apply patient specific factors to determine appropriate candidates for SGLT-2 inhibitors.